Atazanavir Rosiglitazone 807

Reyataz label

Interaction Color Code
Clinical Bottom Line
Administer standard doses
Drug 1
Drug 1 dose
400 mg daily
Drug 2
Drug 2 dose
4 mg x 1
Drug 2 effect

Rosiglitazone AUC increased 35%

Clinical Effects

Potential for increased rosiglitazone adverse effects

Management

Monitor for anti-diabetic agent efficacy if using unboosted atazanavir, and toxicity if using unboosted atazanavir

Import ID
807